Holbrook, Anne M, Eleanor M Pullenayegum, Sue M Troyan, Milica Nikitovic, and Mark A Crowther. “PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN”. Journal of Population Therapeutics and Clinical Pharmacology 20, no. 3 (November 21, 2018). Accessed July 16, 2024. https://jptcp.com/index.php/jptcp/article/view/370.